• National
  • Politics
  • Valley
  • Opinion
  • Money
  • Sports
  • Culture & Lifestyle

  • National
    • Madhesh Province
    • Lumbini Province
    • Bagmati Province
    • National Security
    • Koshi Province
    • Gandaki Province
    • Karnali Province
    • Sudurpaschim Province
  • Politics
  • Valley
    • Kathmandu
    • Lalitpur
    • Bhaktapur
  • Opinion
    • Columns
    • As it is
    • Letters
    • Editorial
    • Cartoon
  • Money
  • Sports
    • Cricket
    • Football
    • International Sports
  • Culture & Lifestyle
    • Arts
    • Brunch with the Post
    • Movies
    • Life & Style
    • Theater
    • Entertainment
    • Books
    • Fashion
  • Health
  • Food
    • Recipes
  • Travel
  • Investigations
  • Climate & Environment
  • World
  • Science & Technology
  • Interviews
  • Visual Stories
  • Crosswords & Sudoku
  • Horoscope
  • Forex
  • Corrections
  • Letters to the Editor
  • Today's ePaper
Tuesday, September 9, 2025

Without Fear or FavourUNWIND IN STYLE

26.01°C Kathmandu
Air Quality in Kathmandu: 148
300+Hazardous
0-50Good
51-100Moderate
101-150Unhealty for Sensitive Groups
151-200Unhealthy
201-300Very Unhealthy
Tue, Sep 9, 2025
26.01°C Kathmandu
Air Quality in Kathmandu: 148
  • What's News :

  • Gen Z protesters
  • Home minister quits
  • Curfew imposed in Valley
  • Nepal’s Gen Z uprising explained
  • Social media ban
  • Mental health

World

India boosts arsenal against Covid-19 with Merck pill, two more vaccines

The emergency approvals come at a time measures are being taken to ramp up oxygen supplies and strengthen the country’s health infrastructure. India boosts arsenal against Covid-19 with Merck pill, two more vaccines
An experimental Covid-19 treatment pill, called molnupiravir and being developed by Merck & Co Inc and Ridgeback Biotherapeutics LP, is seen in this undated handout photo released by Merck & Co Inc and obtained by Reuters May 17, 2021. REUTERS
bookmark
  • facebook
  • twitter
  • Whatsapp
  • mail
Reuters
Published at : December 28, 2021
Updated at : December 28, 2021 20:03
Bengaluru

India has approved Merck’s Covid-19 pill and two more vaccines for emergency use as the world’s second most populous country braces for a possible spike in coronavirus cases due to the rapidly spreading Omicron variant.

Asia’s third-largest economy has already said it will allow Covid-19 booster shots for some of its population as some Indian states logged an uptick in Omicron cases.

The emergency approvals come at a time measures are being taken to ramp up oxygen supplies and strengthen the country’s health infrastructure.

Molnupiravir will be manufactured in India by 13 companies for restricted use under emergency situation for treatment of adult patients with Covid-19, the country’s Health Minister Mansukh Mandaviya said on Tuesday.

Merck’s anti-viral pill molnupiravir was authorised by the United States last week for certain high-risk adult patients and has been shown to reduce hospitalisations and deaths by around 30 percent in a clinical trial.

Earlier this year, Aurobindo Pharma, Cipla, Sun Pharmaceuticals and some others signed non-exclusive voluntary licensing agreements with Merck to manufacture and supply molnupiravir in India.

Two other Covid-19 vaccines, Serum Institute of India’s version of Novavax Inc’s shot, Covovax, and homegrown drugmaker Biological E’s Corbevax were also granted emergency use approval, Mandaviya said on Twitter.

Medical experts have said India needs to double down on its vaccine campaign and some states have imposed night curfews and other restrictions in the run up to New Year festivities to prevent a spike in infections and a repeat of summer 2021 when a devastating second wave of infections left tens of thousands dead.

The country’s inoculation drive so far has been dominated by a domestically produced version of the AstraZeneca  Covid-19 shot by Serum Institute and Bharat Biotech’s inactivated vaccine Covaxin.

India has so far administered 1.43 billion Covid-19 vaccine doses and 62 percent of its eligible population have received both doses. The country plans to start vaccinating those aged 15-18 from January 3.


Related News

US Supreme Court backs Trump on aggressive immigration raids
South Korea to fly detained workers back as US vows more raids on employers
After issuing ‘last warning’ to Hamas, Trump eyes Gaza deal ‘soon’
Explainer: Why E20 fuel is causing angst in India's auto market
Norwegians begin voting in tightly fought parliamentary election
Russia says it struck Ukrainian military targets with drones, missiles and aircraft

Most Read from World

South Korea sees marriages fall by half, births down two-thirds, more foreign spouses
Who were the foreign leaders at China’s military parade?
North Korea wipes traces of Kim Jong Un after Beijing meeting with Putin
Afghanistan earthquake kills 622 with more than 1,500 injured
Earthquake in Afghanistan kills 800, injures 2,800

Editor's Picks

Nepal’s drone industry takes flight, but rules keep it grounded
Hit by Trump’s steep tariffs, garment giants in India turn to Nepal
Transitional justice complaints soar but victims sceptical
Women share how stalking leaves lasting trauma and fear
Birth registration denial robs Nepali children of their future

E-PAPER | September 09, 2025

  • Read ePaper Online
ABOUT US
  • About the Post
  • Masthead
  • Editorial Standards & Integrity
  • Workplace Harassment Policy
  • Privacy Policy
READ US
  • Home Delivery
  • ePaper
CONTACT US
  • Write for the Post
  • Letters to the Editor
  • Advertise in the Post
  • Work for the Post
  • Send us a tip
INTERACT WITH US
  • Twitter
  • Facebook
  • Instagram
OUR SISTER PUBLICATIONS
  • eKantipur
  • saptahik
  • Nepal
  • Nari
  • Radio Kantipur
  • Kantipur TV
© 2025 www.kathmandupost.com
  • Privacy Policy
Top